Search the Newsreel

Wide Open Agriculture Signs Lupin Contract Manufacturing Framework with Proeon

IMDX Looks 289.5% Overvalued on GF Value™

Insight Molecular Diagnostics Inc (IMDX) is considered 284.7% overvalued based on its GF Value™ despite optimism around future FDA authorization for its GraftAssureDx test and expanded Medicare reimbursement. The company reported a Q2 adjusted EBITDA loss and an upward revision of its cash burn …

Insight Molecular Diagnostics Q2 2026 Earnings Preview

* Insight Molecular Diagnostics Inc. (IMDX [https://seekingalpha.com/symbol/IMDX]) is scheduled to announce Q2 earnings results on Monday, August 10th, after market close. * The consensus EPS estimate is -$0.25, [https://seekingalpha.com/symbol/IMDX/earnings/estimates] and the consensus revenue estimate is $0.44M * Over the last year, IMDX has beaten …

Moleculin Biotech, Inc. Actuals & Estimates (NASDAQ:MBRX)

(CGEM) Movement as an Input in Quant Signal Sets

This article analyzes Cullinan Oncology Inc. (NASDAQ: CGEM) using AI models to generate trading strategies. It highlights a strong near-term sentiment possibly leading to a long-term positive bias, with support being tested. The analysis provides specific entry, target, and stop-loss levels for position, momentum …

Hercules plc completes rollout of new Pay and Bill platform

Oculis Holding AG (OCS) stock price, news, quote and history

This article provides comprehensive financial information for Oculis Holding AG (OCS), including its current stock price, historical data, and key financial metrics. It highlights the company's focus on developing drug candidates for ophthalmic, neuro-ophthalmic, and neurological diseases, with lead products in various clinical trial …

Oculis (NASDAQ:OCS) Announces Quarterly Earnings Results

Hercules Capital Inc. (19H.SG) Q1 FY2026 earnings call transcript

Does Ocular Therapeutix (OCUL) Pairing Flat Revenue With a New Shelf Point to a Shifting Funding Strategy?

Ocular Therapeutix (OCUL) reported flat Q2 2026 revenue of US$13.48 million and a widened net loss of US$78.76 million. Coinciding with these results, the company filed an US$81.7 million shelf registration for up to 10 million shares, indicating a strategic move to maintain funding …

4D Molecular Therapeutics Inc (FDMT) Stock News Today

This article provides current stock information for 4D Molecular Therapeutics Inc (FDMT), noting its recent price dip. It states that more news regarding FDMT's earnings, analyst ratings, and key developments will be available soon. The page serves as a hub for investors to track …

Scully Royalty Ltd (SRL) Stock News Today

This article provides real-time stock information for Scully Royalty Ltd (SRL), including its current price, market cap, and recent performance. It notes a lack of recent news updates but encourages users to stay tuned for future developments. The page also offers links to financial …

OCUL Stock Is Climbing Ahead Of Investor Day — What Is On The Agenda?

Ocular Therapeutix (OCUL) shares rose 5% ahead of its Investor Day, driven by the announcement of its regulatory strategy for Axpaxli, an experimental wet age-related macular degeneration (AMD) therapy. The company plans to submit its New Drug Application (NDA) in Q4 2026, supported by …

LeMaitre Vascular, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

LeMaitre Vascular, Inc. recently missed its statutory earnings estimates, causing its shares to drop by 21%. Despite the earnings miss, revenue remained in line with predictions, and analysts have largely maintained their price targets, though they slightly downgraded next year's EPS forecasts. The company …

Ocular Therapeutix (NASDAQ:OCUL) Upgraded to "Hold" at Wall Street Zen

Ocular Therapeutix (NASDAQ:OCUL) has been upgraded from a "sell" to a "hold" rating by Wall Street Zen. The company reported quarterly revenue of $13.47 million and an adjusted loss of $0.35 per share, exceeding analyst estimates. Despite the upgrade, other analysts maintain a "Moderate …

Hercules Capital, Inc. (HTGC) Stock Price, News, Quote & History

This article provides a comprehensive overview of Hercules Capital, Inc. (HTGC), a business development company specializing in venture debt and growth capital. It includes detailed stock information, recent news, historical data, financial performance metrics, analyst ratings, and comparisons with similar companies. The company's focus …

Molecular Partners AG (MOLN) Aktuelle Aktien-News

Cullen/Frost Bankers, Inc. (CFR) Stock forecasts

Cullen/Frost Bankers, Inc. (CFR) is a regional US bank with approximately $54 billion in assets, operating exclusively in the Texas market. The company is noted for its relationship-based banking approach and strong market share. A Morningstar analyst report highlights branch expansion as a significant …

Hercules Capital Inc (HTGC) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Hercules Capital Inc (HTGC), detailing its current earnings forecast score, average price target, and analyst ratings. Based on 9 analysts, the stock has an average price target of $20.25 and is predominantly rated as a "Buy." The …

Cullen/Frost Bankers (NYSE:CFR) Raised to "Strong-Buy" at Zacks Research

Zacks Research has upgraded Cullen/Frost Bankers (NYSE:CFR) to a "strong-buy" rating, despite broader analyst sentiment remaining cautious with a consensus "hold" rating and an average price target of $160.33. The bank's stock opened at $164.83, near its 12-month high, after exceeding analyst expectations with …

Culp Inc (CULP) Stock News Today

This page from TradingKey provides current stock information for Culp Inc (CULP), including its stock price, market capitalization, and P/E TTM. It states that more news is coming soon, with sections for news and analysis, financials, stock score, technical forecast, ownership, dividends, and profile. …

AIRSCULPT TECHNOLOGIES Q2 2026 Earnings Preview: Recent $AIRS Insider Trading, Hedge Fund Activity, and More

AIRSCULPT TECHNOLOGIES ($AIRS) is set to release its Q2 2026 earnings on August 10th, with analysts expecting $45 million in revenue and $0.01 EPS. Insider trading activity shows 13 purchases totaling $1.98 million in the past six months, with no sales. Hedge fund activity …

AirSculpt Technologies Inc expected to post earnings of 1 cent a share - Earnings Preview

AirSculpt Technologies Inc (NASDAQ: AIRS) is projected to report earnings of 1 cent per share. This information is based on an earnings preview from Refinitiv, indicating upcoming financial results for the company. The full article is available for unlimited access through TradingView's news services.

Oculis Holding AG Stock 12‑Month Price Target Cut to $36.26, Implies 193% Upside

Analysts have lowered the 12-month average price target for Oculis Holding AG stock (OCS) to $36.26 from $36.49, with a range of $22.25 to $43.27. Despite the slight reduction, this new target still suggests a significant 193% potential upside from its Aug. 6 closing …

Ocular Therapeutix Options for New Hires Carry $8.40 Price

Ocular Therapeutix (NASDAQ: OCUL) has granted inducement equity awards to eight new non-executive employees, including stock options for up to 53,975 shares and restricted stock units for 17,450 shares, effective August 3, 2026. The stock options have an exercise price of $8.40 per share, …

Molecular Partners AG (MOLN) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for Molecular Partners AG (MOLN), detailing its current earnings forecast score, average price target, and analyst ratings. Based on 5 analysts, the stock has a "Buy" trend with a target price of $13.62, representing a 220.98% upside. The …

31% Undervalued? LeMaitre Vascular (LMAT) After Earnings Guidance And Dividend Update

LeMaitre Vascular (LMAT) reported strong Q2 2026 results with increased sales and net income, affirming its quarterly dividend. While analysts view the stock as 31.4% undervalued with a fair value of $118.75 due to a strong product pipeline and pricing power, Simply Wall St's …

Insight Molecular Diagnostics Inc. (7OC0.MU) Analyst Insights, Price Targets & Recommendations

This article provides analyst insights, price targets, and recommendations for Insight Molecular Diagnostics Inc. (7OC0.MU). It lists several instances where analysts from Lake Street and Needham have maintained a "Buy" rating for the company's stock between February 2026 and April 2025. The current stock …

Airsculpt Technologies Inc (AIRS) Stock News Today

4D Molecular Therapeutics Inc (FDMT) Earnings Forecast: Future EPS & Revenue Growth Estimates

Federal Agricultural Mortgage (AGM) Could Be 59% Overvalued As Strong Earnings Lift Sentiment

4D Molecular Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview

4D Molecular Therapeutics Inc (FDMT) is projected to report a loss of $1.02 per share in its upcoming earnings announcement. This information comes from a Refinitiv earnings preview. The article provides a brief outlook on the company's expected financial performance.

Renaissance Technologies LLC Sells 307,595 Shares of Cullinan Therapeutics, Inc. $CGEM

Renaissance Technologies LLC has reduced its stake in Cullinan Therapeutics (NASDAQ:CGEM) by 48.7% during the first quarter, selling 307,595 shares and retaining 324,111 shares valued at $4.6 million. Despite this sale, institutional investors collectively hold 86.31% of the company's stock, and analysts maintain a …

Culp Inc (CULP) VP reports holding 4,334 common shares

Dekon Food and Agriculture Group Sets August Board Meeting for Interim Results

Agriculture & Natural Solutions Acquisition Corp (ANSC) Stock News Today